(Q38957959)

8 September 2017

title

Cytomegalovirus reactivation in ICU patients (English)

1 reference

8 September 2017

0 references

1

Laurent Papazian

1 reference

8 September 2017

2

Sami Hraiech

1 reference

8 September 2017

Samuel Lehingue

3

1 reference

8 September 2017

Antoine Roch

4

1 reference

8 September 2017

Laurent Chiche

5

1 reference

8 September 2017

Sandrine Wiramus

6

1 reference

8 September 2017

Jean-Marie Forel

7

1 reference

8 September 2017

publication date

30 September 2015

1 reference

8 September 2017

published in

Intensive Care Medicine

1 reference

8 September 2017

volume

42

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

28-37

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-015-4066-9

8 September 2017

exact match

0 references

cites work

The role of viruses in nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Open-lung biopsy in patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Occult herpes family viral infections are endemic in critically ill surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus infection in critically ill patients: associated factors and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Reactivation of multiple viruses in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Viral infections in septic shock (VISS-trial)-crosslinks between inflammation and immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus reactivation and tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

A model for reactivation of CMV from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

The sepsis seesaw: tilting toward immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus colitis in immunocompetent critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Hemophagocytic syndromes and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus infection in critically ill patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

High incidence of active cytomegalovirus infection among septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Occult herpes family viruses may increase mortality in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Active cytomegalovirus infection in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Increased mortality in long-term intensive care patients with active cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus infection monitored by quantitative real-time PCR in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cellular Immunity and Active Human Cytomegalovirus Infection in Patients with Septic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4066-9

Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit

21 January 2018

1 reference

12 December 2020

Reactivation of Human Herpesvirus Type 6 in Multiple Organ Failure Syndrome

1 reference

12 December 2020

Human cytomegalovirus infections in nonimmunosuppressed critically ill patients

1 reference

12 December 2020

Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation

1 reference

12 December 2020

Cytomegalovirus reactivation in critically ill immunocompetent patients

1 reference

12 December 2020

10.1007/S00134-015-4066-9

Identifiers

DOI

1 reference

8 September 2017

0 references

1 reference